Notch receptor expression in Trypanosoma cruzi-infected human umbilical vein endothelial cells treated with benznidazole or simvastatin revealed by microarray analysis
© 2020 International Federation for Cell Biology..
Chagas disease is a vector-borne disease caused by the protozoan parasite Trypanosoma cruzi. Current therapy involves benznidazole. Benznidazole and other drugs can modify gene expression patterns, improving the response to the inflammatory influx induced by T. cruzi and decreasing the endothelial activation or immune cell recruitment, among other effects. Here, we performed a microarray analysis of human umbilical vein endothelial cells (HUVECs) treated with benznidazole and the anti-inflammatory drugs acetylsalicylic acid or simvastatin and infected with T. cruzi. Parasitic infection produces differential expression of a set of genes in HUVECs treated with benznidazole alone or a combination with simvastatin or acetylsalicylic acid. The differentially expressed genes were involved in inflammation, adhesion, cardiac function, and remodeling. Notch1 and high mobility group B1 were genes of interest in this analysis due to their importance in placental development, cardiac development, and inflammation. Quantitative polymerase chain reaction confirmation of these two genes indicated that both are upregulated in the presence of benznidazole.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Cell biology international - 44(2020), 5 vom: 23. Mai, Seite 1112-1123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Campos-Estrada, Carolina [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.12.2020 Date Revised 14.12.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/cbin.11308 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305419862 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305419862 | ||
| 003 | DE-627 | ||
| 005 | 20231225121138.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cbin.11308 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1018.xml |
| 035 | |a (DE-627)NLM305419862 | ||
| 035 | |a (NLM)31943572 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Campos-Estrada, Carolina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Notch receptor expression in Trypanosoma cruzi-infected human umbilical vein endothelial cells treated with benznidazole or simvastatin revealed by microarray analysis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.12.2020 | ||
| 500 | |a Date Revised 14.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 International Federation for Cell Biology. | ||
| 520 | |a Chagas disease is a vector-borne disease caused by the protozoan parasite Trypanosoma cruzi. Current therapy involves benznidazole. Benznidazole and other drugs can modify gene expression patterns, improving the response to the inflammatory influx induced by T. cruzi and decreasing the endothelial activation or immune cell recruitment, among other effects. Here, we performed a microarray analysis of human umbilical vein endothelial cells (HUVECs) treated with benznidazole and the anti-inflammatory drugs acetylsalicylic acid or simvastatin and infected with T. cruzi. Parasitic infection produces differential expression of a set of genes in HUVECs treated with benznidazole alone or a combination with simvastatin or acetylsalicylic acid. The differentially expressed genes were involved in inflammation, adhesion, cardiac function, and remodeling. Notch1 and high mobility group B1 were genes of interest in this analysis due to their importance in placental development, cardiac development, and inflammation. Quantitative polymerase chain reaction confirmation of these two genes indicated that both are upregulated in the presence of benznidazole | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Notch1 | |
| 650 | 4 | |a Trypanosoma cruzi | |
| 650 | 4 | |a benznidazole | |
| 650 | 4 | |a endothelial cells | |
| 650 | 4 | |a simvastatin | |
| 650 | 7 | |a HMGB1 Protein |2 NLM | |
| 650 | 7 | |a HMGB1 protein, human |2 NLM | |
| 650 | 7 | |a NOTCH1 protein, human |2 NLM | |
| 650 | 7 | |a Nitroimidazoles |2 NLM | |
| 650 | 7 | |a Receptor, Notch1 |2 NLM | |
| 650 | 7 | |a Simvastatin |2 NLM | |
| 650 | 7 | |a AGG2FN16EV |2 NLM | |
| 650 | 7 | |a Aspirin |2 NLM | |
| 650 | 7 | |a R16CO5Y76E |2 NLM | |
| 650 | 7 | |a benzonidazole |2 NLM | |
| 650 | 7 | |a YC42NRJ1ZD |2 NLM | |
| 700 | 1 | |a González-Herrera, Fabiola |e verfasserin |4 aut | |
| 700 | 1 | |a Greif, Gonzalo |e verfasserin |4 aut | |
| 700 | 1 | |a Carillo, Ileana |e verfasserin |4 aut | |
| 700 | 1 | |a Guzmán-Rivera, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Liempi, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Robello, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Kemmerling, Ulrike |e verfasserin |4 aut | |
| 700 | 1 | |a Castillo, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Maya, Juan Diego |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell biology international |d 1995 |g 44(2020), 5 vom: 23. Mai, Seite 1112-1123 |w (DE-627)NLM074832263 |x 1095-8355 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2020 |g number:5 |g day:23 |g month:05 |g pages:1112-1123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cbin.11308 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2020 |e 5 |b 23 |c 05 |h 1112-1123 | ||